Dx Antigen
(Die Seite wurde neu angelegt: „{{tp|p=32404480|t=2020. Evaluation of a rapid diagnostic assay for detection of SARS CoV-2 antigen in nasopharyngeal swab.|pdf=|usr=007}} {{tp|p=32508026|t=202…“) |
|||
| Zeile 7: | Zeile 7: | ||
{{tp|p=32485618|t=2020. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis.|pdf=|usr=008}} | {{tp|p=32485618|t=2020. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis.|pdf=|usr=008}} | ||
| − | + | {{tp|p=32356761|t=2020. Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management |pdf=|usr=}} | |
{{tp|p=32382737|t=2020. A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}} | {{tp|p=32382737|t=2020. A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}} | ||
Aktuelle Version vom 26. Juni 2020, 09:43 Uhr
32404480 2020. Evaluation of a rapid diagnostic assay for detection of SARS CoV-2 antigen in nasopharyngeal swab.
32508026 2020. A new and rapid approach for detecting COVID-19 based on S1 protein fragments.
32497809 2020. Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples.
| 32504944 2020. Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital. |
32283141 2020. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients.
32504945 2020. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study.
32485618 2020. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis.
32356761 2020. Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management
32382737 2020. A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019 (COVID-19).
